Skip to main content

Table 3 Drug-related adverse events during the phase III study

From: Long-term observational study in Japanese hemodialysis patients who completed a 3-year clinical study of lanthanum carbonate

Drug-related adverse events (SOC/PT) Patients with events, 16/30 (53.3 %)
  Number of patients Number of events
Endocrine disorders
 Hyperparathyroidism 5 5
Gastrointestinal disorders
 Vomiting 12 41
 Nausea 12 26
 Abdominal discomfort 4 4
 Abdominal pain, upper 3 5
 Diarrhoea 2 7
 Constipation 2 2
 Abdominal pain, lower 1 1
 Faeces, soft 1 1
General disorders and administration site conditions
 Flank pain 1 9
 Chest discomfort 1 1
Investigations
 C-reactive protein increased 1 1
  1. SOC System Organ Class, PT Preferred Term (MedDRA ver. 18.0)